Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 22:344:e874.
doi: 10.1136/bmj.e874.

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

R L Thomas  1 , F Dunstan, S D Luzio, S Roy Chowdury, S L Hale, R V North, R L Gibbins, D R Owens
Affiliations

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

R L Thomas et al. BMJ. .

Abstract

Objectives: To determine the incidence of any and referable diabetic retinopathy in people with type 2 diabetes mellitus attending an annual screening service for retinopathy and whose first screening episode indicated no evidence of retinopathy.

Design: Retrospective four year analysis.

Setting: Screenings at the community based Diabetic Retinopathy Screening Service for Wales, United Kingdom.

Participants: 57,199 people with type 2 diabetes mellitus, who were diagnosed at age 30 years or older and who had no evidence of diabetic retinopathy at their first screening event between 2005 and 2009. 49,763 (87%) had at least one further screening event within the study period and were included in the analysis.

Main outcome measures: Annual incidence and cumulative incidence after four years of any and referable diabetic retinopathy. Relations between available putative risk factors and the onset and progression of retinopathy.

Results: Cumulative incidence of any and referable retinopathy at four years was 360.27 and 11.64 per 1000 people, respectively. From the first to fourth year, the annual incidence of any retinopathy fell from 124.94 to 66.59 per 1000 people, compared with referable retinopathy, which increased slightly from 2.02 to 3.54 per 1000 people. Incidence of referable retinopathy was independently associated with known duration of diabetes, age at diagnosis, and use of insulin treatment. For participants needing insulin treatment with a duration of diabetes of 10 years or more, cumulative incidence of referable retinopathy at one and four years was 9.61 and 30.99 per 1000 people, respectively.

Conclusions: Our analysis supports the extension of the screening interval for people with type 2 diabetes mellitus beyond the currently recommended 12 months, with the possible exception of those with diabetes duration of 10 years or more and on insulin treatment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: this study was funded by the Welsh Office of Research and Development and by an unrestricted educational grant from Takeda UK; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.

References

    1. Bunce C, Wormald R. Causes of blind certifications in England and Wales: April 1999-2000. Eye 2008;22:905-11. - PubMed
    1. Diabetic Retinopathy Study. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse effects to retinopathy severity. Study report no 5. Dev Ophthalmol 1981;2:248-61. - PubMed
    1. Early Treatment Diabetic Retinopathy Research Study Group. Photocoagulation for diabetic macular edema. Study report no 1. Arch Ophthalmol 1985;103:1796-806. - PubMed
    1. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976;81:383-96. - PubMed
    1. James M, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ 2000;320:1627-31. - PMC - PubMed

Publication types

MeSH terms